Regulatory

Start your regulatory journey on the right foot.

The final stretch of regulatory submissions can seem murky – especially when that path takes you through the requirements of multiple countries. Every one of our 1000+ regulatory consultants across 110 countries share a deep understanding of intricate regulatory requirements and a sense of urgency to get important therapies to those who need them. In fact, many of them are former regulators themselves.

Working together, our regulatory consulting services empower you to maintain control of your pathway and stay ahead of any compliance risks. With practical interpretation, we help you understand how guidelines around the world apply to you – including in expanding markets like China.

Our services include:

Meet Our People

With Parexel, a seasoned advisor is always close by and ready to guide your molecule to market, including strategic compliance experts and former FDA, EMA and NMPA employees:

Video: Beginning with the end in mind

Understand how Parexel's Regulatory Services can help you navigate regulatory complexities

Play Now

FDA Releases Draft Guidance on CMC for Gene Therapies

Read Now

FDA Releases a Biopharmaceutical Naming Update

Read Now

The State of Germline Gene Editing. What We Don’t Know!

Read Now

Key Questions to Consider When Licensing Cell & Gene Therapy Products

Read Now

Bispecific Antibody Development Program Guidance

Read Now

New Zealand Draft Therapeutics Product Bill: Are You Prepared?

Read Now

FDA Publishes Guidances Aimed at More Inclusive Eligibility Criteria for Cancer Clinical Trials

Read Now

Four Strategies for Capitalizing on China’s New Generic Drug “4+7” Bulk-Buying Rules

Read Now

Root Cause: Why does Regulatory Approval Not Always Equate to Commercial Success?

Read Now

How New India Clinical Trial Regulations Will Improve Drug Development

Read Now

We are always available for a conversation.

*